Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aspen Aerogels (ASPN) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to $8.1 million.

  • Aspen Aerogels' Other Operating Expenses fell 1273.37% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $335.1 million, marking a year-over-year increase of 76782.77%. This contributed to the annual value of $39.2 million for FY2024, which is 1871.97% up from last year.
  • Aspen Aerogels' Other Operating Expenses amounted to $8.1 million in Q3 2025, which was down 1273.37% from $12.8 million recorded in Q2 2025.
  • In the past 5 years, Aspen Aerogels' Other Operating Expenses ranged from a high of $304.8 million in Q1 2025 and a low of $3.3 million during Q1 2021
  • Its 5-year average for Other Operating Expenses is $23.3 million, with a median of $8.1 million in 2025.
  • Within the past 5 years, the most significant YoY rise in Aspen Aerogels' Other Operating Expenses was 266952.29% (2025), while the steepest drop was 1273.37% (2025).
  • Quarter analysis of 5 years shows Aspen Aerogels' Other Operating Expenses stood at $4.8 million in 2021, then soared by 63.6% to $7.8 million in 2022, then grew by 11.9% to $8.8 million in 2023, then increased by 6.52% to $9.4 million in 2024, then fell by 13.19% to $8.1 million in 2025.
  • Its Other Operating Expenses stands at $8.1 million for Q3 2025, versus $12.8 million for Q2 2025 and $304.8 million for Q1 2025.